Open AccessCommentary on ‘Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)’
Author(s) -
Reiersen Angela M.,
Handen Benjamin
Publication year - 2011
Publication title -
evidence‐based child health: a cochrane review journal
Language(s) - English
Resource type - Journals
ISSN - 1557-6272
DOI - 10.1002/ebch.786
Subject(s) - cochrane collaboration , autism , systematic review , psychiatry , medicine , psychology , medline , meta analysis , cochrane library , political science , law
This is a commentary on a Cochrane review, published in this issue of EBCH, first published as: Williams K, Wheeler DM, Silove N, Hazell P. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews 2010, Issue 8. Art. No.: CD004677. DOI: 10.1002/14 651 858.CD004677.pub2. Further information for this Cochrane review is available in this issue of EBCH in the accompanying Summary article. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. The Cochrane Collaboration